Excalibur Fund Managers is a venture capital firm specializing in early, mid, and late-stage investments. The firm focuses on the medical sciences, biotechnology, and life sciences sectors, targeting companies that bring human medicines or medical devices to market. Excalibur prefers to invest in companies based in the United Kingdom, United States, and Europe, actively participating in their growth by taking board seats.
Notable portfolio companies include Cyclacel, which has raised $26.3 million. Excalibur's key partners are seasoned professionals with extensive experience in the medical and life sciences sectors. The firm's investment philosophy emphasizes active involvement and strategic guidance to help portfolio companies achieve significant milestones. Excalibur offers unique value-add services such as strategic advisory and operational support to ensure the success of its investments.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Stage Mix
Concentration shown as share of disclosed investments by stage.
Classification
- Also Known As
- Excalibur Fund Managers Limited
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 5 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
